Copenhagen
Lund
220 similar offers
Looks like Galecto doesn’t have any active openings at the moment. Here’s a list of alternatives which you might find interesting.
Galecto
Scale-up
The story
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
There are
11 – 50
employees in the company50M to 100M
Company annual revenueOffices
Galecto, Inc is a biotech company with offices in Copenhagen, Boston, London, Montreal, Gothenburg, and Edinburgh. Galecto, Inc develops small molecule based therapeutics for the treatment of severe diseases, focusing on fibrosis and cancer. Our most advanced program is in clinical Phase IIB for the treatment of Idiopathic Pulmonary Fibrosis.
Flexible hours
Remote work
Learn more about Galecto
Markets
Galecto serves clients from Denmark.